文献速递生殖医学

抗苗勒管激素在慢性肾脏病女性、血液透析女性及肾移植后女性中的应用价值

The utility of anti-Müllerian hormone in women with chronic kidney disease, on haemodialysis and after kidney transplantation.
PubMed 文献 · Reprod Biomed Online · 2017-11-28

该研究检测了77例年轻肾功能衰竭女性(26例慢性肾脏病、26例血液透析、25例肾移植)的循环抗苗勒管激素(AMH)浓度,并与600例年龄匹配健康对照比较。血液透析女性随机AMH水平最高[2.9(1.1-5.2)ng/ml],多因素线性回归显示其AMH较其他组高53%[95%CI 0.20-0.98,P=0.002],且AMH随年龄每增加5岁下降20%(P<0.001)。肾功能衰竭女性AMH较健康对照低43%[1.7(0.9-3.8)对3.0(1.9-5.0)ng/ml,P<0.001],但血液透析女性与健康个体间无差异[2.9(1.1-5.2)对3.0(1.9-5.0)ng/ml]。作者认为AMH可能是有用的生物标志物用于非透析依赖肾病女性 pursuing pregnancy,而血液透析中AMH升高不太可能反映卵巢储备。

要点

  • 血液透析女性随机AMH水平最高,多因素回归显示较其他组高53%。
  • 肾功能衰竭女性AMH较年龄匹配健康对照低43%。
  • 血液透析女性与健康个体AMH无差异,作者认为其升高不太可能反映卵巢储备。

核心结论

  • AMH可能是有用的生物标志物用于非透析依赖肾病女性 pursuing pregnancy。
  • 血液透析中AMH水平较高但不太可能反映卵巢储备。

研究设计与样本

  • 检测77例年轻肾功能衰竭女性的循环AMH浓度,其中26例慢性肾脏病、26例血液透析、25例肾移植,并与600例年龄匹配健康个体比较。

主要发现

  • 随机AMH水平血液透析组2.9(1.1-5.2)ng/ml、慢性肾脏病组1.6(0.7-2.2)ng/ml、肾移植组1.5(1.0-4.2)ng/ml,血液透析组最高。
  • 多因素线性回归显示血液透析女性AMH较其他组高53%[95%CI 0.20-0.98,P=0.002],且AMH随年龄每增加5岁下降20%(P<0.001)。
  • 肾功能衰竭女性AMH较600例年龄匹配健康对照低43%[1.7(0.9-3.8)对3.0(1.9-5.0)ng/ml,P<0.001]。
  • 血液透析女性与健康个体AMH无差异[2.9(1.1-5.2)对3.0(1.9-5.0)ng/ml]。

临床怎么用

  • 作者认为AMH可能是有用的生物标志物用于非透析依赖肾病女性 pursuing pregnancy。
  • 作者认为血液透析中AMH水平较高但不太可能反映卵巢储备。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Women with renal disease have menstrual and gonadal dysfunction manifesting as hormonal imbalance. Anti-Müllerian hormone (AMH) is a potential measure of ovarian reserve. We examined circulating AMH concentrations in young women with renal failure, determined associations with clinical characteristics, and compared AMH with age-matched healthy individuals. AMH was measured in 77 women: 26 had chronic kidney disease (CKD), 26 were on haemodialysis (HD), and 25 had a kidney transplant. Random AMH levels were highest in women on HD [HD 2.9 (1.1-5.2), CKD 1.6 (0.7-2.2), transplant 1.5 (1.0-4.2) ng/ml]. On multiple linear regression, AMH was 53% higher [95% CI 0.20-0.98, P = 0.002] in women on HD and decreased by 20% per 5-year increase in age (P < 0.001). AMH was 43% lower in women with renal failure compared with 600 age-matched controls [1.7 (0.9-3.8) versus 3.0 (1.9-5.0) ng/ml, P < 0.001]; however, we found no difference in AMH between those on HD and healthy individuals [2.9 (1.1-5.2) versus 3.0 (1.9-5.0) ng/ml]. AMH may be a useful biomarker in female renal patients with non-dialysis dependent renal disease pursuing pregnancy. In contrast, AMH levels are higher in HD but unlikely to reflect ovarian reserve.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Stoumpos S, Lees J, Welsh P, et al. The utility of anti-Müllerian hormone in women with chronic kidney disease, on haemodialysis and after kidney transplantation. Reprod Biomed Online. 2017. PMID: 29233504. doi:10.1016/j.rbmo.2017.11.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。